4Basra

According to my research, there is a generic version of Imatinib manufactured in India which costs a dollar a tablet, as opposed to $16 – 20 a tablet for the Novartis version in the US or Europe.

As there has been no response from Orion Laboratories (of The Orion Group), and although I will call them anyway, I now need to approach an alternative manufacturer based in India.

I only hope their generic version meets the relevant licensing and certification requirements.

July 13 2006

I reply to the email from the lady running the NGO. She would welcome any assistance in securing supplies of Leukaemia drugs, which are very expensive and beyond the reach of their budget at the moment.

I mention that I have located a manufacturer of the generic Leukaemia drug Imanitib – The Orion Group, who are based in Bangladesh – adding that I am unsure how best to approach them. 

Novartis, are based in Switzerland, and for their part, they run the GIPAP programme, offering the generic version of Glivec. 

Meanwhile, our rental offer on the office in Dublin has been accepted. This is great news and means I can now see if I can find a third guy to share the office, in order to keep the costs to a minimum.